Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
14,202.00
13,117.20
12,172.90
16,071.70
8,497.10
6,557.60
6,710.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
14,202.00
13,117.20
12,172.90
16,071.70
8,497.10
6,557.60
6,710.80
Raw Material Cost
2,451.40
2,244.50
1,705.20
2,723.70
1,355.80
975.40
582.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,681.70
1,537.00
1,195.50
981.40
816.60
705.80
606.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
55.20
73.00
59.40
57.30
56.90
30.20
28.20
Selling and Distribution Expenses
2,899.20
2,539.50
2,115.90
1,824.90
1,346.00
1,341.90
1,556.20
Other Expenses
288.73
237.67
180.12
158.32
162.56
150.37
140.30
Total Expenditure (Excl Depreciation)
9,974.80
8,770.70
6,877.20
7,170.50
5,200.90
4,557.00
4,176.40
Operating Profit (PBDIT) excl Other Income
4227.200000000001
4346.5
5295.700000000001
8901.2
3296.2
2000.6
2534.4
Other Income
726.70
463.00
219.10
50.20
94.70
131.20
89.20
Operating Profit (PBDIT)
5,383.40
5,232.60
5,946.10
9,283.20
3,907.20
2,551.30
2,771.80
Interest
55.20
73.00
59.40
57.30
56.90
30.20
28.20
Exceptional Items
-65.40
-539.30
-686.50
386.10
196.00
118.30
-41.90
Gross Profit (PBDT)
11,750.60
10,872.70
10,467.70
13,348.00
7,141.30
5,582.20
6,128.50
Depreciation
482.90
421.00
341.40
286.20
235.90
210.30
148.20
Profit Before Tax
4,779.90
4,199.30
4,858.80
9,325.80
3,810.40
2,429.10
2,553.50
Tax
367.30
245.70
520.40
1,250.50
297.20
313.30
109.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4,412.60
3,953.60
4,338.40
8,075.30
3,513.20
2,115.80
2,444.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4,412.60
3,953.60
4,338.40
8,075.30
3,513.20
2,115.80
2,444.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4,412.60
3,953.60
4,338.40
8,075.30
3,513.20
2,115.80
2,444.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
29,353.60
25,973.10
22,664.00
18,768.80
11,025.30
11,089.70
8,757.30
Earnings per share (EPS)
38.34
34.77
38.22
71.97
30.52
18.46
21.29
Diluted Earnings per share
38.34
34.77
38.22
71.97
30.52
18.46
21.29
Operating Profit Margin (Excl OI)
29.39%
33.15%
44.24%
55.67%
42.09%
33.7%
37.77%
Gross Profit Margin
37.06%
35.22%
42.72%
59.81%
47.62%
40.25%
40.26%
PAT Margin
31.07%
30.14%
35.64%
50.25%
41.35%
32.26%
36.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 8.27% vs 7.76% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 11.61% vs -8.87% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -2.37% vs -16.72% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -24.38% vs 22.90% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Regeneron Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
14,202.00
10,984.40
3,217.60
29.29%
Other Operating Income
0.00
0.00
0.00
Total Operating income
14,202.00
10,984.40
3,217.60
29.29%
Raw Material Cost
2,451.40
1,530.50
920.90
60.17%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,681.70
0.00
1,681.70
Power Cost
0
0
0.00
Manufacturing Expenses
55.20
30.60
24.60
80.39%
Selling and Distribution Expenses
2,899.20
1,464.30
1,434.90
97.99%
Other Expenses
288.73
359.97
-71.24
-19.79%
Total Expenditure (Excl Depreciation)
9,974.80
6,625.10
3,349.70
50.56%
Operating Profit (PBDIT) excl Other Income
4,227.20
4,359.30
-132.10
-3.03%
Other Income
726.70
545.50
181.20
33.22%
Operating Profit (PBDIT)
5,383.40
5,110.60
272.80
5.34%
Interest
55.20
30.60
24.60
80.39%
Exceptional Items
-65.40
-4,625.70
4,560.30
98.59%
Gross Profit (PBDT)
11,750.60
9,453.90
2,296.70
24.29%
Depreciation
482.90
205.80
277.10
134.65%
Profit Before Tax
4,779.90
248.50
4,531.40
1,823.50%
Tax
367.30
784.10
-416.80
-53.16%
Provisions and contingencies
0
0
0.00
Profit After Tax
4,412.60
-535.60
4,948.20
923.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
4,412.60
-535.60
4,948.20
923.86%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4,412.60
-535.60
4,948.20
923.86%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
29,353.60
16,409.60
12,944.00
78.88%
Earnings per share (EPS)
38.34
-2.08
40.42
1,943.27%
Diluted Earnings per share
38.34
-2.08
40.42
1,943.27%
Operating Profit Margin (Excl OI)
29.39%
39.69%
0.00
-10.30%
Gross Profit Margin
37.06%
4.14%
0.00
32.92%
PAT Margin
31.07%
-4.88%
0.00
35.95%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,420.20 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 8.27% vs 7.76% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 441.26 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 11.61% vs -8.87% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 465.67 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -2.37% vs -16.72% in Dec 2023
Annual - Interest
Interest 5.52 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -24.38% vs 22.90% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.39%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
